carbapenems has been researched along with carbostyril in 62 studies
Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (carbostyril) | Trials (carbostyril) | Recent Studies (post-2010) (carbostyril) |
---|---|---|---|---|---|
7,355 | 147 | 5,277 | 12,855 | 1,323 | 5,611 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (8.06) | 18.2507 |
2000's | 12 (19.35) | 29.6817 |
2010's | 34 (54.84) | 24.3611 |
2020's | 11 (17.74) | 2.80 |
Authors | Studies |
---|---|
Tabuki, K | 1 |
Bergogne-Berezin, E | 1 |
Butler, K; Gress, J; Lecciones, J; Lee, J; Marshall, D; Pizzo, PA; Roilides, E; Rubin, M; Walsh, T; Weinberger, M | 1 |
Coleman, MC; Davis, BW; Demuth, TP; Devries, CA; Hershberger, PM; Imbus, R; Koenigs, PM; Kraft, WG; Paule, SM; Rourke, FJ; Siehnel, RJ; Switzer, AG; Twinem, TL; Yelm, KE; Zoutendam, PH | 1 |
Manzor, O; Pawlak, J; Saravolatz, L | 1 |
Köhler, T; Pechère, C | 1 |
Goldstein, EJ | 1 |
Al Dahouk, S; Dierich, MP; Hofer, E; Neubauer, H; Splettstoesser, WD; Tomaso, H; Treu, TM | 1 |
Paterson, DL | 2 |
Katakami, M; Miyake, Y; Murakami, K; Ono, T; Susilowati, H; Viducic, D | 1 |
Falagas, ME; Koletsi, PK; Kopterides, P; Michalopoulos, A | 1 |
Carmeli, Y; Chmelnitsky, I; Navon-Venezia, S; Strahilevitz, J | 1 |
Koh, TH | 1 |
Aggarwal, P; Capoor, MR; Deb, M; Nair, D; Pillai, P; Posti, J; Singhal, S | 1 |
Fujimoto, H; Kasahara, M; Kinoshita, S; Kofuku, T; Komatsu, M; Nakamura, T; Nakata, C; Nishio, H; Okuda, K; Okura, H; Orita, T; Sakamoto, M; Satoh, K; Shimakawa, K; Shimizu, C; Sueyoshi, N; Takahashi, H; Toyokawa, M; Ura, T; Wada, Y; Yamasaki, K | 1 |
Gales, AC; Nordmann, P; Picão, RC; Poirel, L | 1 |
Cheek, E; Citron, DM; Cubbon, M; Gerding, DN; Lippett, S; Llewelyn, M; Price, J; Sambol, SP | 1 |
Fujita, M; Ishikura, H; Kitamura, T; Matsumoto, T; Toyoshima, H; Watanabe, K; Yoshimura, C | 1 |
De Waele, JJ; Deja, M; Diaz, E; Guven, M; Koulenti, D; Lisboa, T; Mañez, R; Martin-Loeches, I; Putensen, C; Rello, J; Ulldemolins, M | 1 |
Medico, CJ; Walsh, P | 1 |
Chen, YH; Hsueh, PR; Huang, YT; Ko, WC; Lai, CC; Liu, WL; Tan, HR | 1 |
Bernabeu, S; Cherkaoui, A; Nordmann, P; Poirel, L; Renzi, G; Schrenzel, J | 1 |
Haug, JB; Myhr, R; Reikvam, A | 1 |
Clifford, RJ; Hang, J; Kuschner, RA; Kwak, YI; Lesho, EP; McGann, P; Waterman, PE; Yang, Y | 1 |
Cai, JC; Chen, GX; Hu, YY; Sun, Q; Zhang, R; Zhou, HW | 1 |
Ferguson, JK; Harris, PN | 1 |
Hattori, K; Kito, A; Maki, H; Noda, T; Oyama, H; Wada, K | 1 |
Dai, W; Huang, S; Sun, S; Zhang, L; Zhang, X | 1 |
Gotoh, K; Nakamura, K; Ohta, K; Qin, L; Uemura, Y; Watanabe, H | 1 |
Bou, G; Cisneros, JM; Fernández-Cuenca, F; Gato, E; López, M; Martínez-Martínez, L; Pachón, J; Pascual, A; Rodríguez-Baño, J; Ruiz de Alegría, C; Rumbo, C; Tomás, M; Vila, J | 1 |
Chiu, CH; Chung, WH; Hu, HC; Huang, CT; Hung, SI; Kao, KC; Lin, JY; Lin, YF; Rosaline Hui, CY; Sindy, H; Tsai, YC; Wu, TS; Yang, CH | 1 |
Chandran, SP; Diwan, V; Joseph, BV; Lundborg, CS; Macaden, R; Mundayoor, S; Rosales-Klintz, S; Tamhankar, AJ | 1 |
Chen, Z; Li, L; Sun, Z; Tian, L; Wang, Y; Yan, S; Zhang, B; Zhu, X | 1 |
Correia, A; Henriques, IS; Tacão, M | 1 |
Bostanabad, SZ; Feizabadi, MM; Hashemi Shahraki, A; Hashemzadeh, M; Heidarieh, P; Mirsaeidi, M; Nobar, MG | 1 |
Fochat, RC; Manaia, CM; Pereira, TV; Varela, AR; Vaz-Moreira, I | 1 |
Abdile, AA; Doi, Y; Harris, PN; Huh, K; Huxley, RR; O'Neal, CS; Pandeya, N; Paterson, DL; Paynter, S; Shen, AW; Talbot, TR; Wei, JY | 1 |
Betts, J; Liakopoulos, A; Mevius, D; Oikonomou, O; Phee, LM; Wareham, DW | 1 |
Amoh, T; Miyake, Y; Murakami, K; Ono, T; Viducic, D | 2 |
Alberg, T; Blix, HS; Eriksen, HM; Holen, Ø; Neteland, MI; Smith, I | 1 |
Fisher, K; Juang, P; Kollef, MH; Micek, ST; Trupka, T | 1 |
Bruns, T; Büning, J; Fichtner-Feigl, S; Kruis, W; Maaser, C; Preiß, JC; Reuken, PA; Schmelz, R; Stallmach, A; Teich, N | 1 |
Bado, I; Caiata, L; Cordeiro, N; García-Fulgueiras, V; Outeda, M; Papa-Ezdra, R; Seija, V; Vignoli, R | 1 |
Asadi Karam, MR; Bouzari, S; Habibi, M; Shahbazi, S; Talebi, A | 1 |
Avendano, EE; Chan, J; Merchant, S; Puzniak, L; Raman, G | 1 |
Celhay, O; Coast, J; Cooper, BS; Do Thi Thuy, N; Guerin, PJ; Lubell, Y; Oppong, R; Phodha, T; Shrestha, P; Wertheim, H | 1 |
Chen, Y; Jiang, S; Lu, X; Shen, P; Xiao, Y; Yang, P | 1 |
Barcelos, DDP; Bueno, MFC; Casella, T; da Silva, NS; Darini, ALDC; de Andrade, LN; de Oliveira Garcia, D; Franscisco, GR; Lobo, SM; Nogueira, MCL; Polotto, M; Tolentino, FM; Tomaz, FMMB | 1 |
Adachi, Y; Iwata, S; Mokuno, E; Morozumi, M; Sakuma, M; Tajima, T; Ubukata, K | 1 |
Alsharapy, SA; Bertrand, X; Brasme, L; Cholley, P; De Champs, C; Gharout-Sait, A; Guillard, T; Moghram, GS; Muggeo, A; Touati, A | 1 |
Fu, Y; Guo, Y; Li, C; Wang, Y; Zeng, L; Zhang, J; Zhang, X; Zhao, J; Zhao, Y | 1 |
Barreto Crespo, MT; Nunes, M; Oliveira, M; Silva, AF | 1 |
Al-Delaimi, MS; Yacoob Aldosky, HY | 1 |
Goto, K; Itoh, H; Kai, M; Kitano, T; Ohchi, Y; Suzuki, Y; Tanaka, R; Tatsuta, R; Yasuda, N | 1 |
Peters, AT; Pickens, CI; Postelnick, MJ; Qi, C; Wunderink, RG; Zembower, TR | 1 |
Chen, J; Huang, XB; Lv, Y; Wang, C; Wei, DQ; Wu, JY; Xiang, Q | 1 |
Cabañero-Navalón, MD; Garcia-Bustos, V; Salavert Lletí, M | 1 |
Mensa, J; Soriano, A | 1 |
Bai, T; He, Q; Hui, J; Li, X; Liang, L; Lu, J; Tian, N; Yang, R; Zhu, L | 1 |
Ho, HC; Huang, C; Li, W; Liu, C; Shi, L; Xia, H; Yang, L; Yang, X; Zeng, Y; Zhang, W | 1 |
12 review(s) available for carbapenems and carbostyril
Article | Year |
---|---|
The febrile neutropenic patient: newer options for empirical therapy.
Topics: Agranulocytosis; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Fever; Humans; Neutropenia; Quinolones | 1990 |
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa.
Topics: Bacterial Outer Membrane Proteins; Carbapenems; Carrier Proteins; Drug Resistance, Microbial; Membrane Transport Proteins; Microbial Sensitivity Tests; Porins; Pseudomonas aeruginosa; Quinolones | 2001 |
Resistance in gram-negative bacteria: enterobacteriaceae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Quinolones; Urinary Tract Infections | 2006 |
Resistance in gram-negative bacteria: Enterobacteriaceae.
Topics: beta-Lactam Resistance; beta-Lactamases; Carbapenems; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Quinolones | 2006 |
Gram-negative resistance in Singapore: a historical perspective.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; History, 20th Century; History, 21st Century; Humans; Microbial Sensitivity Tests; Quinolones; Singapore | 2008 |
Pharmacotherapy in the critically ill obese patient.
Topics: Aminoglycosides; Antithrombins; Arginine; Body Mass Index; Carbapenems; Cephalosporins; Drug Dosage Calculations; Enoxaparin; Fibrinolytic Agents; Heparin; Humans; Hypnotics and Sedatives; Lipopeptides; Obesity; Oxazolidinones; Penicillins; Pipecolic Acids; Protein C; Quinolones; Recombinant Proteins; Safety; Sulfonamides; Vancomycin | 2010 |
Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Quinolones | 2012 |
Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species: a systematic review with meta-analysis.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; Carbapenems; Cefepime; Cephalosporins; Enterobacteriaceae Infections; Humans; Quinolones; Serratia Infections; Survival Analysis; Treatment Outcome | 2016 |
Risk factors for hospitalized patients with resistant or multidrug-resistant
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Critical Care; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Risk Factors; Vancomycin | 2018 |
Resistance to beta-lactams in Gram-negative bacilli: relevance and potential therapeutic alternatives.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cattle; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Microbial Sensitivity Tests; Quinolones; Tetracyclines | 2022 |
Mechanism of action of cefiderocol.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cattle; Cefepime; Cefiderocol; Ceftazidime; Cephalosporins; Gram-Negative Bacteria; Iron; Quinolones; Serine; Tetracyclines | 2022 |
Relationship between antibiotic exposure and carbapenem-resistant Klebsiella pneumoniae infection within four types of control patients: A systematic review and meta-analysis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Quinolones; Tigecycline | 2023 |
50 other study(ies) available for carbapenems and carbostyril
Article | Year |
---|---|
[Multiply resistant Pseudomonas aeruginosa in the pediatric field].
Topics: Age Factors; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Humans; Infant; Monobactams; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones | 1991 |
[Development of antibiotherapy and new trends].
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Therapy; Humans; Macrolides; Monobactams; Quinolones | 1990 |
Preparation and antimicrobial assessment of 2-thioether-linked quinolonyl-carbapenems.
Topics: Bacterial Proteins; Carbapenems; Carrier Proteins; Cell Division; Gram-Negative Bacteria; Gram-Positive Bacteria; Hexosyltransferases; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Multienzyme Complexes; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Quinolones; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1998 |
In-vitro activity of 29 antimicrobial agents against penicillin-resistant and -intermediate isolates of Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Carbapenems; Cefotaxime; Ceftriaxone; Cephalosporins; Drug Resistance, Multiple; Glycopeptides; Macrolides; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Streptococcus pneumoniae | 1999 |
Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents.
Topics: Abdominal Abscess; Anti-Bacterial Agents; Aza Compounds; Bacteremia; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Ertapenem; Fluoroquinolones; Gemifloxacin; Humans; Indoles; Lactams; Moxifloxacin; Naphthyridines; Quinolines; Quinolones | 2002 |
Antimicrobial susceptibilities of Austrian Francisella tularensis holarctica biovar II strains.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Austria; Carbapenems; Cephalosporins; Chloramphenicol; Francisella tularensis; Hares; Humans; Microbial Sensitivity Tests; Quinolones; Rifampin; Tetracycline; Tularemia | 2005 |
rpoN gene of Pseudomonas aeruginosa alters its susceptibility to quinolones and carbapenems.
Topics: Carbapenems; Gene Expression Regulation, Bacterial; Genes, Bacterial; Promoter Regions, Genetic; Pseudomonas aeruginosa; Quinolones; RNA Polymerase Sigma 54; Transcription, Genetic; Virulence | 2007 |
Exposure to quinolones is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Blood; Carbapenems; Cohort Studies; Colistin; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Penicillins; Quinolones; Retrospective Studies; Risk Factors | 2007 |
Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates.
Topics: Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacter cloacae; Genes, Bacterial; Microbial Sensitivity Tests; Plasmids; Quinolones | 2008 |
Minimum inhibitory concentration of carbapenems and tigecycline against Salmonella spp.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Minocycline; Quinolones; Salmonella; Salmonella Infections; Tigecycline; Typhoid Fever | 2009 |
Monte Carlo simulation for evaluation of the efficacy of carbapenems and new quinolones against ESBL-producing Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Escherichia coli; Humans; Male; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Quinolones | 2009 |
Diversity of beta-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolates causing bloodstream infections in Brazil.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Carbapenems; Ceftazidime; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones | 2009 |
Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Cross Infection; Doxycycline; Drug Utilization; Health Services Research; Hospitals; Humans; Infection Control; Organizational Policy; Prevalence; Quinolones | 2010 |
[A case of hospital-acquired pneumonia caused by intermediately susceptible carbapenem Acinetobacter baumannii].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Carbapenems; Cross Infection; Humans; Male; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Quinolones | 2010 |
Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia.
Topics: Acinetobacter Infections; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Europe; Female; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Piperacillin; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Quinolones; Respiration, Artificial; Severity of Illness Index; Treatment Outcome | 2011 |
Multicenter study in Taiwan of the in vitro activities of nemonoxacin, tigecycline, doripenem, and other antimicrobial agents against clinical isolates of various Nocardia species.
Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Microbial Sensitivity Tests; Minocycline; Nocardia; Quinolones; RNA, Ribosomal, 16S; Tigecycline | 2011 |
Molecular analysis of NDM-1-producing enterobacterial isolates from Geneva, Switzerland.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Conjugation, Genetic; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Hospitals, University; Humans; Multilocus Sequence Typing; Plasmids; Polymerase Chain Reaction; Quinolones; Sequence Analysis, DNA; Switzerland; tRNA Methyltransferases | 2011 |
Pharmacy sales data versus ward stock accounting for the surveillance of broad-spectrum antibiotic use in hospitals.
Topics: Accounting; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Therapy; Drug Utilization; Drug Utilization Review; Hospitals; Humans; Patients' Rooms; Pharmaceutical Services; Quinolones; Reproducibility of Results | 2011 |
Complete sequence of a novel 178-kilobase plasmid carrying bla(NDM-1) in a Providencia stuartii strain isolated in Afghanistan.
Topics: Afghanistan; beta-Lactamases; Burns; Carbapenems; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Open Reading Frames; Plasmids; Providencia; Quinolones; Real-Time Polymerase Chain Reaction | 2012 |
Emergence of Proteus mirabilis harboring blaKPC-2 and qnrD in a Chinese Hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Ciprofloxacin; Clone Cells; Conjugation, Genetic; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Polymerase Chain Reaction; Proteus Infections; Proteus mirabilis; Quinolones; Sequence Analysis, DNA | 2012 |
Inflammatory index and treatment of brain abscess.
Topics: Adult; Aged; Brain Abscess; Carbapenems; Female; Fusobacterium nucleatum; Humans; Male; Middle Aged; Nocardia; Quinolones; Retrospective Studies; Streptococcus milleri Group; Tetracycline; Viridans Streptococci | 2012 |
Prevalence of plasmid-mediated quinolone resistance and aminoglycoside resistance determinants among carbapeneme non-susceptible Enterobacter cloacae.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Plasmids; Quinolones | 2012 |
Comparison study of single and concurrent administrations of carbapenem, new quinolone, and macrolide against in vitro nontypeable Haemophilus influenzae mature biofilms.
Topics: Anti-Bacterial Agents; Biofilms; Carbapenems; Haemophilus Infections; Haemophilus influenzae; Humans; Macrolides; Quinolones | 2013 |
Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; ATP-Binding Cassette Transporters; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Phylogeny; Porins; Quinolones; Tetracyclines | 2013 |
Severe cutaneous adverse reactions related to systemic antibiotics.
Topics: Acute Generalized Exanthematous Pustulosis; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Eruptions; Eosinophilia; Female; Glycopeptides; Humans; Male; Middle Aged; Penicillins; Quinolones; Retrospective Studies; Stevens-Johnson Syndrome; Taiwan | 2014 |
Detection of carbapenem resistance genes and cephalosporin, and quinolone resistance genes along with oqxAB gene in Escherichia coli in hospital wastewater: a matter of concern.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Molecular Sequence Data; Phylogeny; Quinolones; Wastewater | 2014 |
First report in China of Enterobacteriaceae clinical isolates coharboring blaNDM-1 and blaIMP-4 drug resistance genes.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Plasmids; Quinolones; Thienamycins | 2015 |
Low Prevalence of Carbapenem-Resistant Bacteria in River Water: Resistance Is Mostly Related to Intrinsic Mechanisms.
Topics: Aeromonas; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Chloramphenicol; Chromobacterium; Enterobacteriaceae; Environmental Monitoring; Gene Expression; Microbial Sensitivity Tests; Plasmids; Portugal; Pseudomonas; Quinolones; Rivers; Shewanella; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination; Water Microbiology | 2015 |
In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Iran; Linezolid; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Quinolones; Tetracyclines | 2016 |
Multidrug Resistance in Quinolone-Resistant Gram-Negative Bacteria Isolated from Hospital Effluent and the Municipal Wastewater Treatment Plant.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Flavobacteriaceae; Gammaproteobacteria; Gene Expression; Genes, Bacterial; Hospitals; Humans; Integrons; Medical Waste Disposal; Microbial Consortia; Microbial Sensitivity Tests; Portugal; Public Health Surveillance; Quinolones; Wastewater | 2016 |
Providencia stuartii Isolates from Greece: Co-Carriage of Cephalosporin (blaSHV-5, blaVEB-1), Carbapenem (blaVIM-1), and Aminoglycoside (rmtB) Resistance Determinants by a Multidrug-Resistant Outbreak Clone.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Clone Cells; Conjugation, Genetic; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Female; Gene Expression; Gene Transfer, Horizontal; Greece; Humans; Male; Methyltransferases; Microbial Sensitivity Tests; Middle Aged; Plasmids; Providencia; Quinolones; Replicon; Survival Analysis | 2016 |
RpoN Modulates Carbapenem Tolerance in Pseudomonas aeruginosa through Pseudomonas Quinolone Signal and PqsE.
Topics: Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Quinolones; Quorum Sensing; Sigma Factor; Signal Transduction; Trans-Activators | 2016 |
Role of the interplay between quorum sensing regulator VqsR and the Pseudomonas quinolone signal in mediating carbapenem tolerance in Pseudomonas aeruginosa.
Topics: Bacterial Proteins; Carbapenems; Drug Tolerance; Gene Expression Regulation, Bacterial; Mutation; Pseudomonas aeruginosa; Quinolones; Quorum Sensing; Sigma Factor; Signal Transduction; Transcription Factors; Virulence | 2017 |
Broad-spectrum antibiotics in Norwegian hospitals.
Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cephalosporins; Cross Infection; Cross-Sectional Studies; Drug Prescriptions; Drug Resistance, Bacterial; Drug Utilization Review; Guideline Adherence; Hospitals; Humans; Norway; Piperacillin; Quinolones; Respiratory Tract Infections | 2017 |
Enhanced antimicrobial de-escalation for pneumonia in mechanically ventilated patients: a cross-over study.
Topics: Academic Medical Centers; Aged; Anti-Bacterial Agents; Carbapenems; Cefepime; Ceftriaxone; Cephalosporins; Cross-Over Studies; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Middle Aged; Monobactams; Pneumonia; Pneumonia, Ventilator-Associated; Prospective Studies; Quinolones; Respiration, Artificial; Statistics, Nonparametric | 2017 |
Microbial Spectrum of Intra-Abdominal Abscesses in Perforating Crohn's Disease: Results from a Prospective German Registry.
Topics: Abdominal Abscess; Adult; Anti-Bacterial Agents; Antifungal Agents; beta-Lactamase Inhibitors; Candida albicans; Carbapenems; Cephalosporins; Crohn Disease; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterococcus; Female; Germany; Humans; Immunosuppressive Agents; Intestinal Perforation; Length of Stay; Levofloxacin; Male; Penicillins; Prospective Studies; Quinolones; Registries; Streptococcus; Young Adult | 2018 |
Detection of qnrVC6, within a new genetic context, in an NDM-1-producing Citrobacter freundii clinical isolate from Uruguay.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Citrobacter freundii; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Humans; Integrons; Microbial Sensitivity Tests; Middle Aged; Plasmids; Quinolones; Uruguay | 2018 |
Distribution of extended-spectrum β-lactam, quinolone and carbapenem resistance genes, and genetic diversity among uropathogenic Escherichia coli isolates in Tehran, Iran.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Biofilms; Carbapenems; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Genetic Variation; Humans; Iran; Microbial Sensitivity Tests; Middle Aged; Pyelonephritis; Quinolones; Uropathogenic Escherichia coli; Virulence; Virulence Factors; Young Adult | 2018 |
Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Drug Resistance, Bacterial; Drug Utilization; Humans; Macrolides; Quinolones; Thailand; United States | 2018 |
Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; China; Drug Resistance, Bacterial; Drug Utilization; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Penicillins; Prevalence; Pseudomonas aeruginosa; Quinolones; Retrospective Studies; Tertiary Care Centers | 2018 |
Endemicity of the High-Risk Clone
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Quinolones; Tertiary Care Centers | 2019 |
Genetic characteristics and antibiotic resistance of Haemophilus influenzae isolates from pediatric patients with acute otitis media after introduction of 13-valent pneumococcal conjugate vaccine in Japan.
Topics: Acute Disease; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cephalosporins; Child, Preschool; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Japan; Microbial Sensitivity Tests; Multilocus Sequence Typing; Naphthyridines; Otitis Media; Pneumococcal Vaccines; Quinolones; Streptococcus pneumoniae; Vaccines, Conjugate | 2019 |
Characterization of Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Al Thawra University Hospital, Sana'a, Yemen.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Child, Preschool; Clone Cells; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Gene Expression; Hospitals, University; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Plasmids; Quinolones; Yemen | 2020 |
The determination of gyrA and parC mutations and the prevalence of plasmid-mediated quinolone resistance genes in carbapenem resistant Klebsiella pneumonia ST11 and ST76 strains isolated from patients in Heilongjiang Province, China.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; China; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids; Prevalence; Quinolones | 2020 |
The environmental contribution to the dissemination of carbapenem and (fluoro)quinolone resistance genes by discharged and reused wastewater effluents: The role of cellular and extracellular DNA.
Topics: Anti-Bacterial Agents; Carbapenems; DNA; Genes, Bacterial; Humans; Quinolones; RNA, Ribosomal, 16S; Wastewater | 2020 |
Amending the Efficiency of Antimicrobials against Multidrug-Resistant Pseudomonas aeruginosa by Low-Frequency Magnetic Fields.
Topics: Aminoglycosides; Anti-Bacterial Agents; Burns; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Magnetic Fields; Microbial Sensitivity Tests; Penicillins; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones | 2020 |
Simultaneous quantification of plasma levels of 12 antimicrobial agents including carbapenem, anti-methicillin-resistant Staphylococcus aureus agent, quinolone and azole used in intensive care unit using UHPLC-MS/MS method.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Azoles; Carbapenems; Chromatography, High Pressure Liquid; Ciprofloxacin; Daptomycin; Doripenem; Drug Monitoring; Female; Fluconazole; Fluoroquinolones; Humans; Intensive Care Units; Levofloxacin; Linezolid; Male; Meropenem; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazines; Oxazolidinones; Quinolones; Tandem Mass Spectrometry; Tetrazoles; Voriconazole | 2021 |
Decreasing incidence of
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Humans; Incidence; Pneumonia, Bacterial; Quinolones; Retrospective Studies; Vancomycin | 2022 |
Different Effects of Antibiotics on
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Quinolones; Retrospective Studies | 2022 |
Estimating the effect of increasing ambient temperature on antimicrobial resistance in China: A nationwide ecological study with the difference-in-differences approach.
Topics: Anti-Bacterial Agents; Carbapenems; Cefotaxime; Ceftriaxone; Drug Resistance, Bacterial; Escherichia coli; Microbial Sensitivity Tests; Quinolones; Temperature | 2023 |